Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Salmeterol via HandiHaler vs Serevent Diskus
NCT02254187Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2005
- Primary completion
- Oct 2005
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of salmeterol in asthma and chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to infinity up to 8 hours and Maximum measured concentration up to 8 hours. Started Sep 2005; status: completed.
02
Drugs
salmeterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02254187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02254187.